Hyprevention
PrivateLast Round
Series B
Apr 3, 2024
Total Funding Raised
$21.42M
Company Overview
Hyprevention operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series B round in April 2024.
Hyprevention is a medical technology company that develops, manufactures, and sells implantable medical devices designed to reinforce bones weakened by osteoporosis or cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hyprevention Comparables
Compare Hyprevention with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Joline GmbH & Co. KG | 75% | |
| Halma plc | 75% | |
| Merit Medical Systems Inc | 75% |
For institutional investors. Book with your work email.
Hyprevention Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 3, 2024 | ||||
| Series A | Feb 28, 2022 | ||||
| Series A | Sep 28, 2020 | ||||
| Seed | Dec 16, 2015 |
For institutional investors. Book with your work email.
Hyprevention Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yellowstone Holding AG | Series A |
| Business Angels Switzerland | Seed |
| Cercle des Investisseurs de Genève | Seed |
| BeAngels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 28, 2020
Completed a Series A funding round.
- Dec 16, 2015
$820K raised from BeAngels and others.
For institutional investors. Book with your work email.
Hyprevention Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hyprevention's valuation, stock price, and market status.
Is Hyprevention a public or private company?
Hyprevention is a private company.
What is the current stock price of Hyprevention?
Hyprevention is a private company, so its shares have no public market price. Caplight tracks Hyprevention's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hyprevention worth (valuation)?
Valuation information for Hyprevention is not publicly available.
Can I buy Hyprevention stock?
Hyprevention shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hyprevention's last funding round?
Hyprevention's most recent funding round was Series B on April 3, 2024.
Who are the main investors in Hyprevention?
Key investors in Hyprevention include Yellowstone Holding AG, Business Angels Switzerland, Cercle des Investisseurs de Genève, BeAngels.
Will Hyprevention IPO soon?
No public IPO plans have been announced for Hyprevention.
How can I track Hyprevention secondary market activity?
Caplight tracks bids, offers, and trades in Hyprevention's shares on secondary markets.